BOSTON--(BUSINESS WIRE)--Netcapital Inc. (the “Company”) (NASDAQ: NCPL, NCPLW), a digital private capital markets ecosystem, today announced the entry into definitive agreements for the immediate ...
Creative Medical Technology Holdings, Inc., (Nasdaq: CELZ) (the “Company”), a biotechnology company dedicated to the advancement of regenerative therapeutics in the fields of immunotherapy, ...
Helius Medical Technologies, Inc. announced agreements with warrant holders to exercise nearly 4.97 million shares of common stock at a reduced price of $0.751 per share, generating approximately $3.7 ...
Executives exercise previously issued warrants to acquire 200,000 common sharesShares issued in connection with exercise added to existing lock-up agreements ...
BRISBANE, Calif., May 29, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (the “Company”), a clinical-stage biotechnology company developing a pipeline of advanced CAR-T cell ...
DUBLIN, IRELAND / ACCESS Newswire / July 3, 2026 / Great Western Mining Corporation PLC (AIM:GWMO)(ESM:8GW) announces that it has received notices of exercise of warrants over 1,349,255 new ordinary ...
NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (NYSE: ALUR) (the “Company” or “Allurion”), a pioneer in metabolically healthy weight loss, today announced the entry into a definitive ...
Medical technology firm Anteris Technologies Global Corp. (AVR) has filed a Form S-3 registration statement with the SEC, covering the potential issuance of up to 5.39M shares of common stock. The ...
Moleculin Biotech Inc (NASDAQ:MBRX) saw its stock tumble 34.3% in premarket trading Thursday after announcing agreements with certain warrant holders to immediately exercise existing warrants. Under ...
TORONTO, ON / ACCESS Newswire / April 16, 2026 / Galantas Gold Corporation (TSXV:GAL)(AIM:GAL) ("Galantas" or the "Company") announces that it has received notification from shareholder Eric Sprott, ...
BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results